Ranbaxy  has launched its a nasal spray Osonase (Ciclesonide) aqueous in India used in the treatment of perennial and seasonal allergies

Ranbaxy Laboratories Ltd has launched its a nasal spray Osonase (Ciclesonide) aqueous in India used in the treatment of perennial and seasonal allergies. The nasal spray  is in 50mcg strength. Allergic rhinitis affects 10-25 per cent of the global population and is believed to be a precursor for Asthma.

The company had entered the respiratory drug segment in 2005 and has then launched a range of inhalers in the segment.